TY  - GEN
AU  - Powles,Thomas
AU  - Foreshew,Shah-Jalal Sarker
AU  - Shamash,Jonathan
AU  - Sarwar,Naveed
AU  - Crabb,Simon
AU  - Sahdev,Anju
AU  - Nixon,Jude
AU  - Lim,Louise
AU  - Pungaliya,Ashish
AU  - Foreshaw,Abigail
AU  - Davies,Rachel
AU  - Greenwood,Michelle
AU  - Wilson,Peter
AU  - Pacey,Simon
AU  - Galazi,Myra
AU  - Jones,Robert
AU  - Chowdhury,Simon
TI  - A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer
SN  - 1879-0852
PY  - 2014///0826
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Benzimidazoles
KW  - administration & dosage
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cohort Studies
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Everolimus
KW  - Fatigue
KW  - chemically induced
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Kidney Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Quinolones
KW  - Sirolimus
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ejca.2014.04.021
ER  -